SpyGlass Pharma Inc. Common Stock
SGP | NASDAQ
$32.39
-$0.12 (-0.37%)
At close: Oct 30, 2026, 3:59 PM ET
$32.24
-$0.15 (-0.46%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 |
|---|---|---|---|---|
PE Ratio | -13.41 | -24.21 | -69.47 | -22.48 |
PEG Ratio | 0.93 | -0.30 | n/a | n/a |
PS Ratio | n/a | n/a | n/a | n/a |
PB Ratio | 3.20 | 2.06 | -8.93 | -10.12 |
P/FCF Ratio | -14.97 | -15.66 | -47.07 | -98.12 |
P/OCF Ratio | -15.99 | -16.28 | -48.55 | -99.82 |
OCF/S Ratio | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.01 | -0.02 | -0.04 |
Quick Ratio | 25.06 | 38 | 12.67 | 18.11 |
Current Ratio | 25.06 | 38 | 12.67 | 18.11 |
Asset Turnover | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a |
Return on Equity | -8.55% | -5.52% | 12.70% | 11.25% |
Return on Assets | -8.16% | -5.35% | -10.84% | -7.73% |
Return on Invested Capital | -9.39% | -6.12% | -12.70% | -9.18% |
Dividend Yield | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove SGP